UniSuper Management
EW icon

UniSuper Management’s Edwards Lifesciences EW Stock Holding History

UniSuper Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.02M Buy
69,697
+4,900
+8% +$435K 0.03% 270
2026
Q2 		$5.86M Buy
64,797
+11,626
+22% +$974K 0.03% 278
2026
Q1 		$4.26M Sell
53,171
-1,697
-3% -$140K 0.03% 291
2025
Q4 		$4.68M Sell
54,868
-9,163
-14% -$752K 0.03% 272
2025
Q3 		$4.98M Buy
64,031
+14,695
+30% +$1.15M 0.03% 282
2025
Q2 		$3.86M Sell
49,336
-2,709
-5% -$202K 0.03% 296
2025
Q1 		$3.77M Buy
52,045
+1,400
+3% +$100K 0.03% 288
2024
Q4 		$3.75M Sell
50,645
-198,501
-80% -$13.9M 0.03% 281
2024
Q3 		$16.4M Buy
249,146
+209,634
+531% +$15.2M 0.12% 125
2024
Q2 		$3.65M Buy
39,512
+21,442
+119% +$1.9M 0.03% 254
2024
Q1 		$1.73M Sell
18,070
-48,754
-73% -$4.1M 0.02% 285
2023
Q4 		$5.1M Sell
66,824
-3,795
-5% -$264K 0.06% 179
2023
Q3 		$4.89M Sell
70,619
-1,052
-1% -$84.5K 0.06% 176
2023
Q2 		$6.76M Buy
+71,671
New +$6.23M 0.08% 157

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

UniSuper Management's EW Position: Q3 2026 in Review

UniSuper Management increased its Edwards Lifesciences (EW) stake by 7.6% in Q3 2026, buying an estimated $435K and bringing the position to 69,697 shares worth $6.02M. The position accounts for 0.03% of the portfolio, ranked #270.

UniSuper Management first reported a position in EW in Q2 2023 and has held it in 14 quarters since. The position peaked at $16.4M in Q3 2024. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • UniSuper Management held 69,697 shares of Edwards Lifesciences worth $6.02M as of Q3 2026.
  • UniSuper Management bought 4,900 Edwards Lifesciences shares in Q3 2026, an estimated $435K.
  • Edwards Lifesciences made up 0.03% of UniSuper Management's portfolio in Q3 2026, its #270 holding.
  • UniSuper Management first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 14 quarters since.
  • UniSuper Management's Edwards Lifesciences position peaked at $16.4M in Q3 2024.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on UniSuper Management's 13F filing for Q3 2026, filed 26 Oct 2026.